DNA flow cytometry of breast cancer fine needle aspirates
Sir -There are a number of points which I believe should be raised with regard to the article by Mullen and Miller (1989) on DNA flow cytometry of breast cancer fine needle aspirates. First, I would point out that the authors have omitted to reference previous contributions on the same topic (Spyratos et al., 1987; Remvikos et al., 1988a , Briffod et al., 1989 . Second, as a cytometrist, I believe that data file histograms should be presented (rather than redrawn ones) as these usually contain extensive information on the quality of the preparations (baseline, noise, skewed peaks, aggregates). Third, the method of calculation of S-phase values should always be stated.
The most important weakness of the article is the definition of the variations on the histograms. For instance, a modification of more than 5% in DNA index is considered significant, where the standard deviation inherent in the method of calculation (internal standard) is of 4%. From a statistical point of view, a threshold of at least twice the standard deviation should be used, i.e. 8%. Incidentally, the committee on nomenclature of flow cytometry published its recommendations in 1984 (Hiddeman et al., 1984) GENTILE, A. et al. (1987) 
